JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.43 EPS (ttm)7.42 Insider Own0.10% Shs Outstand2.63B Perf Week1.44%
Market Cap469.14B Forward P/E16.61 EPS next Y10.92 Insider Trans-2.79% Shs Float2.63B Perf Month-2.48%
Income19.83B PEG5.27 EPS next Q2.55 Inst Own70.30% Short Float0.67% Perf Quarter12.52%
Sales94.88B P/S4.94 EPS this Y44.70% Inst Trans-0.05% Short Ratio2.25 Perf Half Y13.59%
Book/sh28.42 P/B6.38 EPS next Y6.45% ROA11.10% Target Price190.39 Perf Year6.66%
Cash/sh11.75 P/C15.44 EPS next 5Y4.63% ROE27.50% 52W Range155.72 - 186.69 Perf YTD6.04%
Dividend4.52 P/FCF54.72 EPS past 5Y5.70% ROI19.40% 52W High-2.87% Beta0.66
Dividend %2.49% Quick Ratio1.10 Sales past 5Y5.50% Gross Margin68.00% 52W Low16.45% ATR3.22
Employees141700 Current Ratio1.40 Sales Q/Q5.00% Oper. Margin22.40% RSI (14)56.56 Volatility1.65% 1.72%
OptionableYes Debt/Eq0.44 EPS Q/Q-16.70% Profit Margin20.90% Rel Volume0.76 Prev Close181.40
ShortableYes LT Debt/Eq0.39 EarningsApr 19 BMO Payout56.50% Avg Volume7.76M Price181.34
Recom2.30 SMA201.71% SMA501.46% SMA2006.72% Volume816,847 Change-0.03%
May-23-22Resumed SVB Leerink Outperform $200
Apr-06-22Resumed Morgan Stanley Equal-Weight $173
Mar-16-22Downgrade Bernstein Outperform → Mkt Perform $180 → $183
Mar-02-22Resumed BofA Securities Neutral $185
Dec-17-21Initiated Goldman Neutral $161
Dec-15-21Reiterated Citigroup Buy $192 → $195
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
May-24-22 05:10PM  
12:21PM  
12:06PM  
04:44AM  
May-23-22 02:16PM  
12:16PM  
10:32AM  
10:30AM  
10:19AM  
09:20AM  
May-20-22 10:19AM  
May-19-22 03:20PM  
02:45PM  
12:15PM  
09:50AM  
09:35AM  
09:12AM  
09:00AM  
May-18-22 06:00PM  
10:10AM  
09:39AM  
07:30AM  
May-17-22 10:34AM  
09:38AM  
May-16-22 04:24PM  
09:20AM  
09:18AM  
May-14-22 06:00AM  
05:06AM  
May-13-22 02:08PM  
09:28AM  
09:02AM  
08:00AM  
May-12-22 09:42PM  
02:47PM  
12:16PM  
09:30AM  
09:00AM  
08:58AM  
06:20AM  
06:20AM  
06:20AM  
May-11-22 04:10PM  
09:36AM  
09:06AM  
06:30AM  
06:30AM  
04:00AM  
May-10-22 12:27PM  
10:56AM  
06:20AM  
May-09-22 04:32PM  
12:42PM  
08:05AM  
07:10AM  
06:00AM  
May-06-22 10:29AM  
09:54AM  
07:03AM  
06:56AM  
06:39AM  
06:29AM  
06:20AM  
05:17AM  
May-05-22 05:39PM  
05:35PM  
10:18AM  
10:03AM  
07:42AM  
05:55AM  
May-04-22 10:11AM  
09:23AM  
06:20AM  
06:20AM  
May-03-22 09:30AM  
08:57AM  
May-02-22 05:34PM  
09:48AM  
May-01-22 08:39AM  
Apr-30-22 08:00AM  
Apr-29-22 06:30PM  
02:25PM  
12:45PM  
11:20AM  
09:00AM  
Apr-28-22 03:33PM  
10:53AM  
09:01AM  
06:15AM  
Apr-27-22 05:01PM  
11:53AM  
11:10AM  
10:53AM  
10:29AM  
07:17AM  
06:20AM  
Apr-26-22 06:41PM  
06:06PM  
05:59PM  
04:19PM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and healthcare professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hait WilliamSee RemarksApr 21Option Exercise90.4429,6992,685,978109,935Apr 25 04:33 PM
Hait WilliamSee RemarksApr 21Sale183.5829,6995,452,05380,236Apr 25 04:33 PM
Mongon ThibautExec VP, WW Chair, ConsumerMar 17Option Exercise100.6930,7853,099,89574,688Mar 21 04:38 PM
Mongon ThibautExec VP, WW Chair, ConsumerMar 17Sale176.2610,8741,916,67163,814Mar 21 04:38 PM
Mongon ThibautExec VP, WW Chair, ConsumerMar 17Sale176.2523,6814,173,71840,133Mar 21 04:38 PM
Decker Robert JController, CAOMar 15Option Exercise72.545,000362,70020,473Mar 17 04:30 PM
Decker Robert JController, CAOMar 15Sale175.515,000877,53015,473Mar 17 04:30 PM
Ullmann Michael HExec VP, General CounselFeb 15Option Exercise0.0013,1860165,044Feb 17 06:00 AM
Broadhurst VanessaEVP, Global Corp Aff.Feb 15Option Exercise0.002,557016,592Feb 17 06:00 AM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 15Option Exercise0.0018,0640135,297Feb 17 06:01 AM
Mammen MathaiEVP, Pharm, R&DFeb 15Option Exercise0.007,740045,300Feb 17 06:00 AM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 15Option Exercise0.0010,386076,010Feb 17 06:01 AM
Duato JoaquinCEOFeb 15Option Exercise0.0029,7140258,879Feb 17 06:00 AM
Gorsky AlexDirectorFeb 15Option Exercise0.0060,9650611,919Feb 17 06:00 AM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 15Option Exercise0.0015,806048,055Feb 17 06:01 AM
Wolk Joseph JExec VP, CFOFeb 15Option Exercise0.0017,793043,177Feb 17 06:01 AM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 15Option Exercise0.003,922045,746Feb 17 06:01 AM
Decker Robert JController, CAOFeb 15Option Exercise0.00903015,721Feb 17 06:01 AM
Hait WilliamSee RemarksFeb 15Option Exercise0.008,128084,394Feb 18 07:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 14Option Exercise0.0011,1540118,497Feb 17 06:00 AM
Wolk Joseph JExec VP, CFOFeb 14Option Exercise0.003,248026,305Feb 15 08:04 PM
Hait WilliamSee RemarksFeb 14Option Exercise0.007,7900230,948Feb 15 08:04 PM
Duato JoaquinCEOFeb 14Option Exercise0.005,4240231,521Feb 15 08:04 PM
Gorsky AlexDirectorFeb 14Option Exercise0.0011,1290555,787Feb 15 08:04 PM
Decker Robert JController, CAOFeb 14Option Exercise0.00866015,081Feb 15 08:02 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 14Option Exercise0.002,885033,041Feb 15 08:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 14Option Exercise0.003,759043,344Feb 15 08:03 PM
Ullmann Michael HExec VP, General CounselFeb 14Option Exercise0.002,4070152,729Feb 15 08:03 PM
Broadhurst VanessaEVP, Global Corp Aff.Feb 14Option Exercise0.002,451014,937Feb 15 08:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 14Option Exercise0.001,896066,319Feb 15 08:03 PM
Mammen MathaiEVP, Pharm, R&DFeb 14Option Exercise0.007,418039,895Feb 15 08:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 14Option Exercise0.003,2970118,423Feb 15 08:02 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 14Option Exercise0.002,0360109,379Feb 15 08:02 PM
Duato JoaquinCEOJan 14Option Exercise65.3784,4235,518,732280,475Jan 19 08:54 PM
Gorsky AlexDirectorJan 14Option Exercise65.37231,95115,162,637695,601Jan 19 08:54 PM
Decker Robert JController, CAODec 07Option Exercise72.545,000362,70019,215Dec 09 04:43 PM
Decker Robert JController, CAODec 07Sale163.215,000816,05014,215Dec 09 04:43 PM